Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors
Igor A. Schepetkin(Montana State University), Mark T. Quinn(Montana State University)
Cited by 13
Related Papers
Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors
|Molecular Pharmacology|2012|87
Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia–Reperfusion
|Biomedicines|2022|12
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors
|Frontiers in Pharmacology|2022|11